The correlations between LAMP2 expression and various clinicopathological features highlight the need to pay more attention to patients over the age of 60 and those without Barrett’s esophagus or distal tumor central location in order to improve their clinical outcomes. Here, LAMP2 is linked to esophageal adenocarcinoma.